The effects of green kiwifruit combined with isoflavones on equol production, bone turnover and gut microflora in healthy postmenopausal women

Asia Pacific Journal of Clinical Nutrition

Volumn 27, Issue 2, 2018, Pages 347-358

  Kruger, Marlena C ^a   Middlemiss, Catherine ^a   Katsumata, Shinichi ^b   Tousen, Yuko ^c   Ishimi, Yoshiko ^c  

^a MASSEY UNIVERSITY   (New Zealand)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^c NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Bone markers; Gut microbiota; Isoflavones; Kiwifruit; Postmenopausal women

Indexed keywords

BIOLOGICAL MARKER; DAIDZEIN; GENISTEIN; ISOFLAVONE DERIVATIVE;

ACTINIDIA; BLOOD; BONE; FEMALE; FRUIT; HUMAN; INTESTINE FLORA; METABOLISM; MIDDLE AGED; POSTMENOPAUSE; URINE;

ACTINIDIA; BIOMARKERS; BONE AND BONES; FEMALE; FRUIT; GASTROINTESTINAL MICROBIOME; GENISTEIN; HUMANS; ISOFLAVONES; MIDDLE AGED; POSTMENOPAUSE;

EID: 85041283634     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.6133/apjcn.062017.06     Document Type: Article

References (65)

1. Kessen K. New approaches to the pharmacological treatment of osteoporosis. Bull World Health Organ. 2003; 81:657-64
2. Wehrli FW, Rajapakse S, Magland JF, Snyder PJ. Mechanical implications of estrogen supplementation in early postmenopausal women. J Bone Miner Res. 2010;25: 1406-14. doi: 10.1002/jbmr.33
3. Brown P, McNeill R, Radwan E, Willingale J. The Burden of Osteoporosis in New Zealand: 2007-2020 2007. [cited 2016/08/01]; Available from: http://www.iofbonehealth. org/sites/default/files/PDFs/white_paper_new_zealand_2007.pdf
4. The Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288:321-33. doi:10.1001/jama.288.3.321
5. Jackson RL, Greiwe JS, Schwen RJ. Emerging evidence of the health benefits of S-equol, an estrogen receptor ß agonist. Nutr Rev. 2011;69:432-48. doi: 10.1111/j.1753-4887.2011. 00400.x
6. Lye H-S, Kuan C-Y, Ewe J-A, Fung W-Y, Liong M-T. The improvement of hypertension by probiotics: Effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci. 2009;10:3755-75. doi: 10.3390/ijms10093755
7. Park K, Ju WC, Yeo JH, Kim JY, Seo HS, Uchida Y, Cho Y. Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation. Int J Mol Med. 2014;33:178-84. doi: 10.3892/ijmm.2013.1557
8. Dang Z, Lowick CW. The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J Bone Miner Res. 2004;19: 853-61. doi: 10.1359/jbmr.040120
9. Bao L, Zou S, Zhang S. Dose-dependent effects of daidzein in regulating bone formation through estrogen receptors and peroxisome proliferator-activated receptor . Chin J Integr Med. 2011;9:165-72. doi: 10.3736/jcim20110209
10. Suh KS, Koh G, Park CV, Woo JT, Kim SW, Kim JW, Park IK, Kim YS. Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells. Phytochemistry. 2003;63:209-15. doi: 10.1016/S0031-942 2(03)00101-8
11. De Wilde A, Lieberherr M, Colin C, Pointillart A. A low dose of daidzein acts as an ERß-selective agonist in trabecular osteoblasts of young female piglets. J Cell Physiol. 2004;200:253-62. doi: 10.1002/jcp.20008
12. Castelo-Branco C, Hidalgo MJ. Isoflavones: effects on bone health. Climacteric. 2011;14:204-11. doi: 10.3109/ 1369713 7.2010.529198
13. Levis S, Strickman-Stein N, Ganjei-Azar P, Xu P, Doerge DR, Krischer J. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. Arch Intern Med. 2011; 171:363-9. doi: 10.1001/archinternmed.2011.330
14. Wong WW, Lewis RD, Steinberg FM, Murray MJ, Cramer MA, Amato P et al. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial. Am J Clin Nutr. 2009;90:433-9. doi: 10.3945/ajcn.2009.28001
15. Alekel DL, Van Loan MD, Koehler KJ, Hanson LN, Stewart JW, Hanson KB, Kurzer MS, Peterson CT. The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women. Am J Clin Nutr. 2010;91:218-30. doi: 10.3945/ajcn.2009.28306
16. Pawlowski JW, Martin BR, McCabe GP, McCabe L, Jackson GS, Peacock M, Barnes S, Weaver CM. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial. Am J Clin Nutr. 2015;102:695-703. doi: 10.3945/ajcn.114.093906
17. Vatanparast H, Chilibeck PD. Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype? Nut Rev. 2007;65:294-9. doi: 10.1111/j.1753-4887.2007.tb00307.x
18. Lauderdale DS, Jacobsen SJ, Furner SE, Levy PS, Brody, JA, Goldberg J.Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol. 1996;146:502-9. doi: 10.1093/oxfordjournals.aje.a009304
19. Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr. 2001;131: 1202-6
20. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdamn Jr JW. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998;68: 1375-9
21. Ma D-F, Qin L-Q, Wang P-Y, Katoh R. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: Meta-analysis of randomized controlled trials. Clin Nutr. 2008;27:57-64. doi: 10.1016/j. clnu.2007.10.012
22. Taku K, Melby MK, Kurzer MS, Mizuno S, Watanabe S, Ishimi Y. Effects of soy isoflavone supplements on bone turnover markers in menopausal women: Systematic review and meta-analysis of randomized controlled trials. Bone. 2010;47:413-23. doi: 10.1016/j.bone.2010.05.001
23. Ma D-F, Qin L-Q, Wang P-Y, Katoh R. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: Meta-analyses of randomised controlled trials. Eur J Clin Nutr. 2008;62:155-61. doi: 10.1038/sj.ejcn.1602748
24. Taku K, Melby MK, Kurzer MS, Mizuno S, Watanabe S, Ishimi Y. Effects of soy isoflavone supplements on bone turnover markers in menopausal women: Systematic review and meta-analysis of randomized controlled trials. Bone. 2010;47:413-23. doi: 10.1016/j.bone.2010.05.001
25. Taku K, Melby MK, Nishi N, Omori T, Kurzer MS. Soy isoflavones for osteoporosis: An evidence-based approach. Maturitas. 2011;70:333-8. doi: 10.1016/j.maturitas.2011.09. 001
26. Uehara M. Isoflavone metabolism and bone-sparing effects of daidzein-metabolites. J Clin Biochem Nutr. 2013;52:193-201. doi: 10.3164/jcbn.13-2
27. Kimira YK, Katsumata S-I, Suzuki K, Ishimi Y, Ueno T, Uchiyama S, Adlerkreautz H, Uehara M. Comparative activities of the S-enantiomer and racemic forms of equol on bone fragility in ovariectomized mice. Biosci Biotechnol Biochem. 2012;76:1018-21. doi: 10.1271/bbb.110973
28. Sanchez-Calvo JM, Rodriguez-Iglesias MA, Molinillo JM. G., Macias FA. Soy isoflavones and their relationship with microflora: Beneficial effects on human health in equol producers. Phytochem Rev. 2013;12:979-1000. doi: 10. 1007/s11101-013-9329-x
29. Setchell KDR, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D et al. S-equol, a potent ligand for estrogen receptor ß, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005;81:1072-9
30. Wu J, Oka J, Higuchi M, Tabata I, Toda T, Fujioka M et al. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metabolism. 2006;55: 423-33. doi: 10.1016/j.metabol.2005.10.002
31. Wu J, Oka J, Ezaki J, Ohtomo T, Ueno T, Uchiyama S, Toshiya T, Uehara M, Ishimi Y. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause. 2007;14:866-74. doi: 10.1097/gme.0b013e3180305299
32. Tousen Y, Ezaki, J, Fujii Y, Ueno T, Nishimuta M, Ishimi Y. Natural S-equol decreases bone resorption in postmenopausal non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial. Menopause. 2011; 18:563-74. doi: 10.1097/gme.0b013e3181f85aa7
33. Hong K-W, Ko K-P, Ahn Y, Kim C-S, Park S-J, Park JK, Kim S, Kim Y. Epidemiological profiles between equol producers and nonproducers: A genomewide association study of the equol-producing phenotype. Genes Nutr. 2012;7: 567-74. doi: 10.1007/s12263-012-0292-8
34. Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Proc Soc Exp Biol. 2005;230: 155-70. doi: 10.1177/153537020523000302
35. Setchell KDR, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr. 2006; 136:2188-93
36. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: Influence of habitual diet. Proc Soc Exp Biol Med. 1998;217:335-9. doi: 10. 3181/00379727-217-44241
37. Ohta A, Uehara M, Sakai K, Takasaki M, Adlercreutz H, Morohashi T, Ishimi Y. A combination of dietary fructooligosaccharides and isoflavone conjugates increase femoral bone mineral density and equol production in ovariectomized mice. J Nutr. 2002;132:2048-54
38. Tousen Y, Abe F, Ishida T, Uehara M, Ishimi Y. Resistant starch promotes equol production and inhibits tibial bone loss in ovariectomized mice treated with daidzein. Metabolism. 2011;60:1425-32. doi: 10.1016/j.metabol.2011. 02.009
39. Lee YK, Low KY, Siah K, Drummond LM, Gwee, K-A. Kiwifruit (Actinidia deliciosa) changes intestinal microbial profile. Microb Ecol Health Dis. 2012;23:15-9. doi: 10. 3402/mehd.v23i0.18572
40. Rosendale DI, Blatchford PA, Sims IM, Shanthi GP, Carnachan SM, Hedderley D, Ansell J. Characterizing kiwifruit carbohydrate utilization in vitro and its consequences for human faecal microbiota. J Proteome Res. 2012;11:5863-75. doi: 10.1021/pr300646m
41. Tousen Y, Wolber FM, Chua W-H, Tadaishi M, Ishimi Y, Kruger MC. Effects of daidzein and kiwifruit on bone mineral density and equol production in ovariectomised rats. Int J Food Sci Nutr. 2013;18:1-8. doi: 10.3109/09637486. 2013.858238
42. Tousen Y, Uehara M, Kruger MC, Ishimi Y. Effects of dietary fibre and tea catechin, ingredients of the Japanese diet, on equol production and bone mineral density in isoflavone-treated ovariectomised mice. J Nutr Sci. 2012;1: 1-9. doi: 10.1017/jns.2012.14
43. Nagashima K, Hisada T, Sato M, Mochizuki J. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol. 2003; 69:1251-62. doi: 10.1128/AEM.69.2.1251-1262.2003
44. Nagashima K, Mochizuki J, Hisada T, Suzuki S, Shimomura K. Phylogenetic analysis of 16S ribosomal RNA gene sequences from human faecal microbiota and improved utility of terminal restriction fragment length polymorphism profiling. Bioscience Microflora. 2006;25:99-107. doi: 10. 12938/bifidus.25.99
45. Brown H, Prescott R. Applied mixed models in medicine, 2nd edition. New Jersey, USA: John Wiley & Sons Ltd; 2014. doi: 10.1002/0470023589
46. Sowers MFR, Zheng H, McConnell D, Nan B, Harlow S, Randolph JF. Follicle-stimulating hormone and its rate of change in defining menopause transition stages. J Clin Endocrinol Metab. 2008;93:21-5. doi: 10.1210/jc.2008-0482
47. Ross CA, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96: 53-58. doi: 10.1210/jc.2010-2704
48. Holic MF, Binkley NC, Bischoff-Ferrari H, Gordon CM, Hanley DA, Heaney RP, Hassan Murad M, Weaner CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:1911-30. doi: 10.1210/jc. 011-0385
49. Anderson, Paul H, Lam, N N, Turner, AG, Davey RA, Kogawa M, Atkins G J, Morris HA. The pleiotropic effects of vitamin D in bone. J Steroid Biochem Mol Biol. 2013; 136:190-4. doi: 10.1016/j.jsbmb.2012.08.008
50. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19:73-8. doi: 10.1016/j.annepidem.2007.12.001
51. Feskanich D, Willett WC, Colditz GA. Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr. 2003;77: 504-11
52. Valderas JP, Velasco S, Solari S, Liberona Y, Viviani P, Maiz A, Escalona A, Gonzalez G. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after roux-en-Y gastric bypass. J Metab Surgery Allied Care. 2009;19:1132-8. doi: 10. 1007/s11695-009-9890-y
53. Albertazzi P, Steel SA, Bottazzi M. Effect of pure genistein on bone markers and hot flushes. Climacteric. 2005;8:371-9. doi: 10.1080/13697130500345257
54. Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Squadrito F. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women. Annals Int Med. 2007;146:839-47. doi: 10.7326/ 0003-4819-146-12-200706190-00005
55. Hill T, Collins A, O'Brien M, Kiely M, Flynn A, Cashman KD. Vitamin D intake and status in Irish postmenopausal women. Eur J Clin Nutr. 2005;59:404-10. doi: 10.1038/sj. ejcn.1602088
56. Yasui T, Miyatani Y, Tomita J, Yamada M, Uemura H, Miura M, Irahara M. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women. Gynecol Endocrinol. 2006;22:455-9. doi: 10.1080/ 09513590600900402
57. Binkley NC, Krueger DC, Engelke JA, Foley AL, Suttie JW. Vitamin K supplementation reduces serum concentrations of undercarboxylated osteocalcin in healthy young and elderly adults. Am J Clin Nutr. 2000;72:1523-8
58. Szulc P, Chapuy M-C, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone. 2003;18:487-8. doi: 10.1172/JCI116387
59. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS study. J Clin Endocrinol Metab. 1997; 82:3-8. doi: 10.1210/jcem.82.3.3805
60. Sokoll LJ, Booth SJ, O'Brien ME, Davidson KW, Tsaloun KI, Sadowski JA. Changes in serum osteocalcin, plasma phyloquinone and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr. 1997;65:779-84
61. Wolber FM, Beck KL, Conlon CA, Kruger MC. Kiwifruit and mineral nutrition. In: Advances in Food and Nutrition Research. Boland M, Moughan PJ, editors. New York: Elsevier Inc; 2013. doi: 10.1016/B978-0-12-394294-4. 00013-4
62. Levis S, Strickman-Stein N, Ganjei-Azar P, Xu P. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Arch Int Med. 2005;171:1363-9. doi: 10.1001/archinternmed.2011.330
63. Katsumata S, Wolber FM, Tadaishi M, Tousen Y, Ishimi Y, Kruger MC. Effect of kiwifruit on bone resorption in ovariectomized mice. J Nutr Sci Vitamol. 2015;61:332-7. doi: 10.3177/jnsv.61.332
64. Han KS, Balan P, Molist Gasa F, Boland M. Green kiwifruit modulates the colonic microbiota in growing pigs. Lett Appl Microbiol. 2011;52:379-85. doi: 10.1111/j.1472-765X.2011.03012.x
65. Raimondi S, Roncaglia L, De Lucia M, Amaretti A, Leonardi A, Pagnoni UM, Rossi M. Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl Microbiol Biotechnol. 2009;81:943-50. doi: 10. 1007/s00253-008-1719-4